Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensus
M Lambrecht, DBP Eekers, C Alapetite… - Radiotherapy and …, 2018 - Elsevier
Purpose For unbiased comparison of different radiation modalities and techniques,
consensus on delineation of radiation sensitive organs at risk (OARs) and on their dose …
consensus on delineation of radiation sensitive organs at risk (OARs) and on their dose …
60 years of neuroendocrinology: acromegaly
C Capatina, JAH Wass - Journal of Endocrinology, 2015 - joe.bioscientifica.com
Acromegaly (ACM) is a chronic, progressive disorder caused by the persistent
hypersecretion of GH, in the vast majority of cases secreted by a pituitary adenoma. The …
hypersecretion of GH, in the vast majority of cases secreted by a pituitary adenoma. The …
American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly-2011 update
L Katznelson, JLD Atkinson, DM Cook… - Endocrine …, 2011 - endocrinepractice.org
AACE= American Association of Clinical Endocrinologists; BEL=“best evidence” level;
BMD= bone mineral density; CPAP= continuous positive airway pressure; CPG= clinical …
BMD= bone mineral density; CPAP= continuous positive airway pressure; CPG= clinical …
[PDF][PDF] Epidemiology of male hypogonadism
A Thirumalai, BD Anawalt - Endocrinology and metabolism clinics of North …, 2022 - Elsevier
The best available evidence indicates that the most common endogenous pathologic cause
of hypogonadism is Klinefelter syndrome (affecting up to∼ 0.2% of the male population) …
of hypogonadism is Klinefelter syndrome (affecting up to∼ 0.2% of the male population) …
Management of nonfunctioning pituitary tumors: radiotherapy
G Minniti, J Flickinger, B Tolu, S Paolini - Pituitary, 2018 - Springer
External beam radiotherapy (RT) is an essential part of the management of intracranial
tumors and has been used in treating pituitary adenomas for more than five decades. It has …
tumors and has been used in treating pituitary adenomas for more than five decades. It has …
Congress of neurological surgeons systematic review and evidence-based guideline for the management of patients with residual or recurrent nonfunctioning pituitary …
BACKGROUND: Despite the advancement of microsurgical and endoscopic techniques,
some nonfunctioning pituitary adenomas (NFPAs) can be difficult to cure. Tumor recurrence …
some nonfunctioning pituitary adenomas (NFPAs) can be difficult to cure. Tumor recurrence …
Long-term outcomes after Gamma Knife radiosurgery for patients with a nonfunctioning pituitary adenoma
R Gopalan, D Schlesinger, ML Vance, E Laws… - …, 2011 - journals.lww.com
BACKGROUND: Nonfunctioning pituitary adenomas recur after microsurgery. Gamma Knife
radiosurgery (GKRS) has been used to treat recurrent adenomas. OBJECTIVE: To evaluate …
radiosurgery (GKRS) has been used to treat recurrent adenomas. OBJECTIVE: To evaluate …
Gamma Knife surgery for patients with nonfunctioning pituitary macroadenomas: predictors of tumor control, neurological deficits, and hypopituitarism
Object Nonfunctioning pituitary macroadenomas often recur after microsurgery and thereby
require further treatment. Gamma Knife surgery (GKS) has been used to treat recurrent …
require further treatment. Gamma Knife surgery (GKS) has been used to treat recurrent …
Radiation-induced hypopituitarism
A Fernandez, M Brada, L Zabuliene… - Endocrine-related …, 2009 - erc.bioscientifica.com
The hypothalamic–pituitary unit is a particularly radiosensitive region in the central nervous
system. As a consequence, hypopituitarism commonly develops after radiation treatments …
system. As a consequence, hypopituitarism commonly develops after radiation treatments …
Early versus late Gamma Knife radiosurgery following transsphenoidal surgery for nonfunctioning pituitary macroadenomas: a multicenter matched-cohort study
OBJECTIVE Gamma Knife radiosurgery (GKRS) is frequently used to treat residual or
recurrent nonfunctioning pituitary macroadenomas. There is no consensus as to whether …
recurrent nonfunctioning pituitary macroadenomas. There is no consensus as to whether …